DUSP7 and acute myeloid leukemia: KM survival curves in GSE71014, TCGA-LAML, and TARGET-AML cohorts all showed that the AML patients with high DUSP7 expression might have a poor prognosis (Figure 3(d), GSE71014, HR = 2.64, P=0.009; Figure 3(e), TARGET-AML, HR = 1.72, P < 0.001; Figure 3(f), TCGA-LAML, HR = 2.27, P < 0.001).